HK125096A - Expectorant comprising hydroxy-alkylcysteine derivative - Google Patents

Expectorant comprising hydroxy-alkylcysteine derivative

Info

Publication number
HK125096A
HK125096A HK125096A HK125096A HK125096A HK 125096 A HK125096 A HK 125096A HK 125096 A HK125096 A HK 125096A HK 125096 A HK125096 A HK 125096A HK 125096 A HK125096 A HK 125096A
Authority
HK
Hong Kong
Prior art keywords
expectorant
hydroxy
alkylcysteine
derivative
alkylcysteine derivative
Prior art date
Application number
HK125096A
Other languages
English (en)
Inventor
Yoshikuni Itoh
Miroyuku Mizuno
Chikako Kiyohara
Susumu Sato
Tatsuhiko Katori
Original Assignee
Ss Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ss Pharmaceutical Co filed Critical Ss Pharmaceutical Co
Publication of HK125096A publication Critical patent/HK125096A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK125096A 1988-06-16 1996-07-11 Expectorant comprising hydroxy-alkylcysteine derivative HK125096A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63148653A JPH0788352B2 (ja) 1988-06-16 1988-06-16 ヒドロキシアルキルシステイン誘導体およびこれを含有する去痰剤

Publications (1)

Publication Number Publication Date
HK125096A true HK125096A (en) 1996-07-19

Family

ID=15457618

Family Applications (1)

Application Number Title Priority Date Filing Date
HK125096A HK125096A (en) 1988-06-16 1996-07-11 Expectorant comprising hydroxy-alkylcysteine derivative

Country Status (8)

Country Link
US (2) US4906665A (fr)
EP (2) EP0346883B1 (fr)
JP (1) JPH0788352B2 (fr)
KR (2) KR950004677B1 (fr)
CA (2) CA1312090C (fr)
DE (2) DE68915341T2 (fr)
ES (2) ES2056153T3 (fr)
HK (1) HK125096A (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0788352B2 (ja) * 1988-06-16 1995-09-27 エスエス製薬株式会社 ヒドロキシアルキルシステイン誘導体およびこれを含有する去痰剤
JP4098850B2 (ja) * 1997-07-16 2008-06-11 久光製薬株式会社 Ｓ−（３−ヒドロキシプロピル）−ｌ−システインを含有する経口用製剤
JP2000133368A (ja) 1998-10-20 2000-05-12 Yazaki Corp 防水コネクタとダミー栓の係止構造
US20040147606A1 (en) * 2001-05-25 2004-07-29 Yoichi Onuki Medicinal compositions
JP3805646B2 (ja) 2001-05-25 2006-08-02 久光メディカル株式会社 医薬液剤
JP4365106B2 (ja) * 2001-05-25 2009-11-18 エスエス製薬株式会社 医薬配合剤
JP4490668B2 (ja) * 2003-10-23 2010-06-30 田辺三菱製薬株式会社 下痢治療薬
WO2007040188A1 (fr) * 2005-10-03 2007-04-12 Sankyo Company, Limited Composition médicinale pour inhiber la formation excessive de cellules caliciformes
GB2462022B (en) 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof
CN102180820B (zh) * 2011-03-16 2014-03-12 四川科伦药物研究有限公司 一种制备高纯度福多司坦的纯化方法
CN103768011A (zh) * 2012-10-23 2014-05-07 天津药物研究院 福多司坦注射剂及其制备方法
CN103113273B (zh) * 2013-02-01 2014-09-10 浙江国邦药业有限公司 一种福多司坦的合成方法
CN104418779B (zh) * 2013-08-26 2017-08-08 天方药业有限公司 高纯度福多司坦的制备方法
CN104326954B (zh) * 2014-10-17 2016-03-30 宜昌东阳光长江药业股份有限公司 一种福多司坦的合成方法
CN106432021B (zh) * 2016-09-23 2018-03-27 威海迪素制药有限公司 一种福多司坦结晶的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3111M (fr) * 1963-12-02 1965-02-08 Rech S Pharma Et Scient Médicament a base de dérivé de cystéine.
US4085217A (en) * 1964-01-29 1978-04-18 L'oreal Process and cosmetic compositions for the treatment of skin and scalp
US3891749A (en) * 1969-10-07 1975-06-24 Rech Pharm Scientifiques Digestive pharmaceutical composition comprising S-carboxymethyl cysteine for reducing viscosity of respiratory tract secretions, and method of treating therewith
FR2187326B1 (fr) * 1972-06-15 1975-10-17 Rech Pharm Scientifiques
US4005222A (en) * 1975-05-21 1977-01-25 Mead Johnson & Company Mucolytic mercaptoacylamidobenzoic and benzenesulfonic acid compounds and process
ES469060A1 (es) * 1978-04-22 1979-04-01 Invest Tecnica Aplicada Procedimiento para la preparacion de nuevos derivados tio- prenilicos con actividad farmacologica
ES8502967A1 (es) * 1983-08-08 1985-02-01 Vinas Lab Procedimiento para la obtencion de un nuevo derivado de carbocisteina
JPH0788352B2 (ja) * 1988-06-16 1995-09-27 エスエス製薬株式会社 ヒドロキシアルキルシステイン誘導体およびこれを含有する去痰剤

Also Published As

Publication number Publication date
JPH0788352B2 (ja) 1995-09-27
US4906665A (en) 1990-03-06
KR950004677B1 (ko) 1995-05-04
CA1312090C (fr) 1992-12-29
ES2059625T3 (es) 1994-11-16
ES2056153T3 (es) 1994-10-01
EP0346883A3 (en) 1990-10-10
DE68909501T2 (de) 1994-05-05
EP0346882A2 (fr) 1989-12-20
EP0346882B1 (fr) 1993-09-29
CA1325597C (fr) 1993-12-28
EP0346883B1 (fr) 1994-05-18
EP0346882A3 (en) 1990-12-12
US5047428A (en) 1991-09-10
KR900000336A (ko) 1990-01-30
DE68915341D1 (de) 1994-06-23
KR900000335A (ko) 1990-01-30
DE68909501D1 (de) 1993-11-04
DE68915341T2 (de) 1995-02-16
EP0346883A2 (fr) 1989-12-20
KR950004676B1 (ko) 1995-05-04
JPH023674A (ja) 1990-01-09

Similar Documents

Publication Publication Date Title
YU222289A (en) Hinuklidin derivatives
GB8905443D0 (en) Dihalogrnobenzene derivatives
HK125096A (en) Expectorant comprising hydroxy-alkylcysteine derivative
GB2222828B (en) Butynylamine derivatives
PH27571A (en) Capsiacin derivatives
EG19385A (en) N-phenylpyrazol -4-yl-ether derivatives
IL89230A0 (en) Acylphenol derivatives
ZA89860B (en) Pyranobenzoxadiazole derivatives
PH27235A (en) Benzopyranol derivatives
ZA892723B (en) Phosphonoalkylpurine derivatives
GB2222829B (en) Benzylidenecyclanone derivatives
YU200589A (en) Derivatives 3-acyl-2-oxyndol-1-carboxamida
EP0355353A3 (en) Cycloalkylthiazole derivatives
GB8813160D0 (en) Therapeutic methods
ZA898604B (en) Pyranylethyl-naphthalene derivatives
ZA893169B (en) 3-cyano-4-phenyl-pyrrole derivatives
ZA899582B (en) Benzohydroxymic derivatives
IE881922L (en) Benzodipyran derivative
IE883203L (en) Thiadiazinone derivative
IE881871L (en) Doxorubicin derivative
IE891897L (en) Cholestadiene derivative
GB8817210D0 (en) Dolls
FI103406B1 (fi) 3-piperatsinyylibentsatsolijohdannainen
GB8817949D0 (en) Flasklet ii
IE883569L (en) Cycloocteneimine derivatives

Legal Events

Date Code Title Description
PF Patent in force
AS Change of ownership

Owner name: BIOMEDIX CO., LTD.

Free format text: FORMER OWNER(S): SS PHARMACEUTICAL CO., LTD

CHPA Change of a particular in the register (except of change of ownership)
CHPA Change of a particular in the register (except of change of ownership)
PE Patent expired

Effective date: 20090613